Loading clinical trials...
Loading clinical trials...
The purposes of this study are to: 1. test among adolescent the utility of brief video-based interventions to reduce stigma-related attitudes and increase help-seeking intentions toward depression; 2. examine the role of race (Black vs other) as an independent factor in the primary outcome.
Intervention videos will each be of \~120-second duration and feature an underage female professional (age 16) acting as a simulated patient. All three videos will focus on her as an empowered presenter with depression sharing her personal story regarding depression and describe how social supports from family, friends, and community, as well as professional help assisted her in overcoming symptoms of the illness. Assessments will occur at baseline and post-intervention, and will include: 1. Demographics (baseline only); 2. Primary outcome: Depression-related stigma(Depression Stigma Scale \[DSS\]) summary score. 3. Secondary outcomes: a. DSS individual items; b. Help-seeking (General Help-Seeking Questionnaire \[GHSQ\]) summary score and individual items; and bc Racial attitudes: feelings thermometers. The investigators intend to randomly assign \~1,000 individuals aged 14-18 as follows: Subjects oversampled for Black participants (50% Black; 50% other); Randomized, in equal proportions, and stratified by race, to view one of three \~120-second videos of a girl with: 1. No depression control (Black; BC); 2. Depression (Black, following same script as in our earlier study (Amsalem and Martin, 2021), DB); and 3. Depression adjusted (Black, with script adjusted based on input from focus group of Black girls and women; DBa).
Age
14 - 18 years
Sex
ALL
Healthy Volunteers
Yes
Yale Child Study Center
New Haven, Connecticut, United States
Start Date
July 15, 2021
Primary Completion Date
August 7, 2021
Completion Date
August 7, 2021
Last Updated
August 25, 2021
1,291
ACTUAL participants
Short videos
BEHAVIORAL
Lead Sponsor
Yale University
NCT07360600
NCT06793397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions